Targeting of Notch1 as a therapeutic strategy has undergone extensive investigation, utilizing various methods for its inhibition in cancer treatment, including Notch1 monoclonal antibodies, Notch1 siRNA, and γ-secretase inhibitors26. This evidence concerns the gene NOTCH1 and cancer.